Cogent Biosciences is a biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine ki...
Use this information to figure out if this company is an ideal customer for you.
617.945.5576
200 Cambridge Park Drive
Cambridge, 02140
201 - 500 Employees
$50M - $100M
linkedin.com/company/cogentbiosciences
Cogent Biosciences's CEO is Kristin Tzetzo
Cogent Biosciences's CTO is Brad Barnett
Cogent Biosciences's CFO is John Green
Cogent Biosciences's HQ is located at 200 Cambridge Park Drive, Cambridge
Cogent Biosciences's phone number is 617.945.5576
Cogent Biosciences's official website is cogentbio.com
Cogent Biosciences's revenue is $50M - $100M
Cogent Biosciences has 201 - 500 employees
Cogent Biosciences is in the industry of: Biotechnology
